Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	12.94	96.45	85.40
Graham Fair Price	3.25	47.57	46.07
PEG	561.71	105.70	-15.97
Price/Book	6.25	12.46	11.73
Price/Cash Flow	-50.90	150.49	306.51
Prices/Earnings	12.54	35.95	31.95
Price/Sales	13.19	51.00	45.06
Price/FCF	-50.90	150.49	306.51
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	2.52	0.70	0.68
Operating Margin	2.30	0.45	0.44
ROA	-2.53	0.05	0.05
ROE	0.09	0.09	-5.58
ROIC	0.07	0.07	-1.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.20	0.04	407.27
Dividends QOQ	0.10	< 0.005	-99.78
EBIT QOQ	< 0.005	0.02	298.70
EPS QOQ	-0.02	< 0.005	-82.99
FCF QOQ	-0.56	1.30	132.52
Revenue QOQ	0.10	< 0.005	-97.32
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.41	6.34	-14.38
Days Sales Outstanding (DSO)	62.15	64.06	3.07
Inventory Turnover	12.15	14.19	16.79
Debt/Capitalization	0.24	0.22	-8.06
Quick Ratio	1.02	1.05	2.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	32.06	34.07	6.26
Cash	10.90	10.77	-1.17
Capex	-1.31	-1.47	-12.52
Free Cash Flow	1.23	2.82	129.96
Revenue	8.34	8.32	-0.25
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.22	1.24	1.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.12	2.58	21.66
Naive Interpretation	Member

06 - Financial Health · Weak

Rating